| Literature DB >> 32829676 |
Renske A B Oude Nijhuis1, Margot van der Hoek1, Jeroen M Schuitenmaker1, Marlies P Schijven2, Werner A Draaisma3, Andreas J P M Smout1, Albert J Bredenoord1.
Abstract
BACKGROUND: Accurate information on the natural course of giant paraesophageal hernia is scarce, challenging therapeutic decisions whether or not to operate.Entities:
Keywords: Paraesophageal hernia; acute symptoms; complication; conservative therapy; hiatal hernia; intrathoracic stomach; watchful waiting
Mesh:
Year: 2020 PMID: 32829676 PMCID: PMC7724529 DOI: 10.1177/2050640620953754
Source DB: PubMed Journal: United European Gastroenterol J ISSN: 2050-6406 Impact factor: 4.623
Figure 1.Flow chart of case findings.
Baseline characteristics in patients with giant paraesophageal hernia.
Total study population ( | Conservative( | Surgical( | ||||
|---|---|---|---|---|---|---|
| % | Mean(SD) or median (IQR) | |||||
| Sex | 0.867 | |||||
| Male | 91/293 | 31.1 | 65/220 (29.5) | 19/62 (30.6) | ||
| Female | 202/293 | 68.9 | 155/220 (70.5) | 43/62 (69.4) | ||
| Age at diagnosis (years), mean (SD) | 70.3 (12.4) | 73.0 (11.6) | 61.8 (9.6) | <0.001 | ||
| Caucasian | 220/293 | 75.1 | 165/220 (75.0) | 47/62 (75.8) | 0.897 | |
| BMI,[ | 27.02 (4.7–31.1) | 28.9 (24.7–31.1) | 27.7 (25.0–31.6) | 0.360 | ||
| ASA ≥3 | 86/288 | 29.9 | 79/215 (36.7) | 2/62 (3.2) | <0.001 | |
| Intoxications | ||||||
| History of smoking | 76/211 | 36.0 | 56/164 (34.1) | 18/62 (40.0) | 0.467 | |
| Alcohol use >2 units per day | 21/196 | 10.7 | 18/152 (11.8) | 3/43 (7.0) | 0.364 | |
| Medical history | ||||||
| Cardiac disease | 40/289 | 13.8 | 34/216 (15.7) | 4/62 (6.5) | 0.061 | |
| Vascular disease | 34/289 | 11.8 | 27/216 (12.5) | 5/62 (8.1) | 0.335 | |
| COPD | 32/289 | 11.1 | 24/216 (11.1) | 8/62 (12.9) | 0.697 | |
| Diabetes mellitus | 30/289 | 10.4 | 23/216 (10.6) | 7/62 (11.3) | 0.886 | |
| Concomitant oesophageal carcinoma | 9/293 | 3.1 | 8/220 (3.6) | 1/62 (1.6) | 0.423 | |
ASA: American Society of Anesthesiologists; BMI: body mass index; IQR: interquartile range; COPD: chronic obstructive pulmonary disease; SD: standard deviation.
aNumber of patients.
bTotal number of patients in whom data could be obtained.
cn = 173.
Clinical, endoscopic and radiological characteristics of patients with giant paraesophageal hernia.
Total study population ( | Conservative( | Surgical( | |||
|---|---|---|---|---|---|
| % | |||||
| Symptoms at diagnosis | 179/293 | 61.1 | |||
| Asymptomatic | 114/293 | 38.9 | 114/220 (51.8) | 0/62(0.0) | <0.001 |
| Incidental finding | 166/280 | 59.3 | 159/215(74.0) | 4/55(7.3) | <0.001 |
| Type of symptoms | |||||
| Heartburn | 61/284 | 21.5 | 36/213 (16.9) | 25/61 (41.0) | <0.001 |
| Respiratory symptoms | 61/284 | 21.5 | 41/213 (19.2) | 18/61 (29.5) | 0.086 |
| Epigastric pain | 51/284 | 18.0 | 21/213 (9.9) | 26/61 (42.6) | <0.001 |
| Dysphagia | 42/284 | 14.8 | 17/213 (8.0) | 24/61 (39.3) | <0.001 |
| Nausea and/or vomiting | 39/284 | 13.7 | 21/213 (9.9) | 13/61 (21.3) | 0.017 |
| Chest pain | 38/284 | 13.4 | 20/213 (9.4) | 16/61 (26.2) | 0.001 |
| Weight loss | 24/284 | 8.5 | 9/213 (4.2) | 14/61 (23.0) | <0.001 |
| Regurgitation | 22/284 | 7.7 | 7/213 (3.3) | 15/61 (24.6) | <0.001 |
| Postprandial fullness | 15/284 | 5.3 | 8/213 (3.8) | 7/61 (11.5) | 0.019 |
| Belching | 6/284 | 2.1 | 3/213 (1.4) | 3/61 (4.9) | 0.099 |
| Hernia-related complications | 25[ | 8.5 | 11/220 (5.0) | 3/62 (4.8) | 0.959 |
| Obstruction | 15 | 60.0 | |||
| Gastrointestinal bleeding | 6 | 24.0 | |||
| Obstruction with ischaemia | 4 | 16.0 | |||
| Respiratory/cardiac compression | 2 | 8.0 | |||
| Gastric/oesophageal perforation | 1 | 4.0 | |||
| Laboratory findings | |||||
| Iron deficiency anaemia | 50/274 | 18.2 | 42/208 (20.2) | 7/57 (12.3) | 0.173 |
| Endoscopic findings | |||||
| Reflux oesophagitis | 16/111 | 14.4 | 7/68 (10.3) | 8/40 (20.0) | 0.159 |
| Cameron lesions | 7/111 | 6.3 | 3/68 (4.4) | 4/40 (10.0) | 0.255 |
| Barrett’s oesophagus | 13/111 | 11.7 | 7/68 (10.3) | 5/40 (12.5) | 0.725 |
| Gastrointestinal ulcer(s) | 4/111 | 3.6 | 4/68 (5.9) | 0/40 (0.0) | 0.118 |
aNumber of patients.
bTotal number of patients in whom data were obtained.
cNumber of patients with one or multiple hernia-related complications at diagnosis.
Radiological diagnosis of patients with giant paraesophageal hernia.
Total study population( | Conservative( | Surgical( | ||
|---|---|---|---|---|
| Radiological diagnosis | ||||
| CT scan | 52/293 (17.7) | |||
| Chest radiograph | 91/293 (31.1) | |||
| Barium oesophagram | 56/293 (19.1) | |||
| Combination of tests listed above | 94/293 (32.1) | |||
| Hernia anatomy | 0.976 | |||
| Type III hiatal hernia | 266/293 (90.8) | 202/220 (91.8) | 57/62 (91.9) | |
| Type IV hiatal hernia | 27/293 (9.2) | 18/220 (8.2) | 5/62 (8.1) |
CT: computed tomography.
aNumber of patients.
bTotal number of patients in whom data were obtained.
Figure 2.Long-term outcomes in the 186 conservatively treated patients in whom follow-up data could be obtained.
Logistic regression analysis for identifying risk factors for ‘hernia-related complications’ in conservatively treated patients.
| Demographic and clinical characteristics | Univariable | ||
|---|---|---|---|
| OR | 95% CI | ||
| Male sex | 2.117 | 0.729–6.125 | 0.168 |
| Age | 1.019 | 0.969–1.071 | 0.462 |
| BMI | 0.991 | 0.912–1.076 | 0.830 |
| ASA ≥3 | 0.273 | 0.059–1.261 | 0.096 |
| Smoking | 1.533 | 0.502–4.658 | 0.453 |
| Alcohol use >2 units/day | 2.850 | 0.688–11.799 | 0.149 |
| Use of risk medication[ | 0.331 | 0.041–2.643 | 0.297 |
| Disease-specific characteristics | |||
| Hernia type IV | 2.477 | 00.490–12.515 | 0.272 |
| Complete herniation of stomach in chest cavity | 2.183 | 0.733–6.507 | 0.161 |
| Presence of symptoms at diagnosis | 4.444 | 1.211–16.312 | 0.025 |
| Duration of symptoms | 2.183 | 0.733–6.507 | 0.161 |
| Type of symptoms at diagnosis | |||
| Dysphagia | 2.153 | 0.431–10.749 | 0.350 |
| Postprandial fullness | 4.472 | 0.813–24.588 | 0.085 |
| Heartburn | 1.151 | 0.303–4.366 | 0.837 |
| Respiratory symptoms | 1.107 | 0.292–4.197 | 0.085 |
| Regurgitation | – | – | – |
| Chest pain | 6.071 | 1.788–20.617 | 0.004 |
| Epigastric pain | 4.371 | 1.213–15.757 | 0.024 |
| Belching | 12.769 | 0.755–216.100 | 0.078 |
| Weight loss | 1.758 | 0.201–15.402 | 0.610 |
| Nausea/vomiting | 15.700 | 4.602–53.566 | <0.001 |
| Iron deficiency anaemia | 0.593 | 0.127–2.770 | 0.506 |
| Endoscopic findings | |||
| Reflux oesophagitis | 1.714 | 0.167–17.626 | 0.650 |
| Cameron lesions | 17.000 | 1.334–216.666 | 0.029 |
| Barrett | – | – | – |
| Ulcer(s) | 3.571 | 0.285–44.718 | 0.324 |
ASA: American Society of Anesthesiologists; BMI: body mass index; CI: confidence interval; OR: odds ratio.
aRisk medication was defined as medication associated with a potentially damaging effect on gastric mucosa, such as anticoagulants, corticosteroids, selective serotonin re-uptake inhibitors or non-steroidal anti-inflammatory drugs.